Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients

Léa Dubreuil, Patrice Chevallier, Christelle Retière, Katia Gagne

Open source

DOI
10.3390/cancers13153767
Published
2021-07-27
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers13153767,
  title = {Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients},
  author = {Léa Dubreuil and Patrice Chevallier and Christelle Retière and Katia Gagne},
  year = {2021},
  journal = {Cancers},
  doi = {10.3390/cancers13153767},
  url = {https://doi.org/10.3390/cancers13153767}
}

RIS

TY  - JOUR
TI  - Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
AU  - Léa Dubreuil
AU  - Patrice Chevallier
AU  - Christelle Retière
AU  - Katia Gagne
PY  - 2021
JO  - Cancers
DO  - 10.3390/cancers13153767
UR  - https://doi.org/10.3390/cancers13153767
ER  - 

APA

Dubreuil, L., Chevallier, P., Retière, C., & Gagne, K. (2021). Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients. Cancers. https://doi.org/10.3390/cancers13153767

Source records